News
Children with resistant UTIs unexpectedly may respond to discordant antibiotics
January 17, 2020
A low rate of care escalation and high rate of clinical improvement suggest this may be a reasonable approach until urine culture sensitivities return.
News
SPRINT-type BP control provides up to 3 years of additional life
January 14, 2020
PHILADELPHIA – Survival advantage of intensive over standard blood pressure lowering is age dependent.
News
Treatment of heart failure with preserved ejection fraction is a work in progress
January 13, 2020
Although the disorder has a lower mortality than heart failure with reduced ejection fraction, it places a significant burden on health care systems.
News
PACT-HF: Transitional care derives no overall benefit
January 9, 2020
PHILADELPHIA – A trial of a postdischarge transitional care model found no improvement in outcomes overall, but showed that women responded more favorably than men.
News
New hypertension performance measures boost 130/80 mm Hg target
January 6, 2020
PHILADELPHIA – Hypertension performance and quality measures from the AHA and ACC provide a guide for implementing the 2017 hypertension guideline.
News
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
December 16, 2019
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.
News
New ASH guideline: VTE prophylaxis after major surgery
December 12, 2019
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.
News
Cardiac arrhythmia heightens mortality risk during epilepsy hospitalizations
December 11, 2019
BALTIMORE – A secondary diagnosis of apnea is not independently associated with increased odds of death, however.
News
Genetic test stratified AFib patients with low CHA2DS2-VASc scores
December 9, 2019
A 32-locus genetic test classified AFib patients with low CHA2DS2-VASc scores into high– and low–stroke-risk subgroups.
News
New heart failure trial data presage guideline revisions
December 9, 2019
PHILADELPHIA – Recent trial findings for sacubitril/valsartan and dapagliflozin in heart failure patients provide a blueprint for guideline changes.